Q4 2018 Investor Presentation
Number of Patient Lives Impacted
> Growth Strategy & Strategic Initiatives
Changing lives with every breath
20 million lives changed in 2020
Improve patient quality of life
Slow chronic disease progression
Reduce healthcare system costs
•
Horizon 3
Invest in Portfolio of
New Market Options
Sleep & Consumer Wellness
- Engagement in Sleep Health
Horizon 1
Lead SDB Industry
Ground breaking end-to-end
connected health solutions
.
Horizon 2
Scale-Up Respiratory Care
and Connected COPD
Connected respiratory care solutions
for COPD, obesity-hypoventilation
syndrome, and neuromuscular
disease, including ALS
Integrate with connected solutions
•
- Expansion of ResMed brand
Connected Health Expansion
- Connected devices, analytics, population
health models
- Out of hospital SaaS Solutions
- Care coordination
• Adjacent Market Development
- A-Fib, HFPEF, Asthma
Expansion in High Growth Markets - China, E. Europe, India, Brazil, S.E. Asia
Time to Material Growth Impact
PEOPLE, LEADERSHIP AND CULTURE
GLOBAL LEADERSHIP IN DIGITAL AND CONNECTED HEALTH
OPERATING EXCELLENCE - LEVERAGE MARKET-LEADING SCALE
© 2018 ResMed I Q4 2018 Investor Presentation | 6
ResMedView entire presentation